NEWS


Research carried out by Beatriz Hanaoka, MD (Division of Clinical Immunology and Rheumatology) and Prabhakara Nagareddy, Ph.D. (Department of Nutrition Sciences) identifies novel possible therapies for patients with rheumatoid arthritis and potential for cardiovascular disease. Read more


S. Louis Bridges, Jr, MD, PhD, Anna Lois Waters Endowed Chair of the UAB Division of Clinical Immunology and Rheumatology, named vice president of the Rheumatology Research Foundation. Read more


The  2017 CAMBAC Research Day
Friday, December 1, 2017

Led by Kenneth Saag, MD, Phase two of clinical gout trial begins at UAB. For details click here


UAB-led study shows drug effectiveness in reducing glucocorticoid-induced bone loss. Click here for more


UAB expert highlights need to do more trials in the epidemic center of disease. Read more here


Frances Lund, PhD, UAB immunology leader, spoke at Vatican City international conference. Click here for details


Archived News Stories


Keynote Speaker

Buckner 2Dr. Buckner received her bachelor’s degree in chemistry from Carleton College, magna cum laude. She attended Johns Hopkins School of Medicine, and after receiving her MD, she completed her residency training in Internal Medicine at the University of Minnesota. Dr. Buckner went on to complete a fellowship in rheumatology at the University of Washington. Since 1999, Dr. Buckner has been an investigator at the Benaroya Research Institute (BRI). She became the Director of the Translational Research Program at BRI in 2005, was named Associate Director of BRI in January 2012 and was appointed President of BRI in January 2016. Dr. Buckner continues to care for rheumatology patients at the Virginia Mason Medical Center, and she is an affiliate Professor of Medicine in the Division of Rheumatology at the University of Washington. Dr. Buckner’s laboratory is focused on identifying the underlying mechanisms by which regulation of the adaptive immune response fails or is overcome in the setting of human autoimmunity. The diseases studied in Dr. Buckner’s laboratory include type 1 diabetes (T1D), multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus and relapsing polychondritis